Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1_2
1
100%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1/2Combined phases
1(100.0%)

Highest Phase Reached

Phase 1/2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Completed(1)

Detailed Status

Completed1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
100.0%
Most Advanced
Phase 1/2

Trials by Phase

Phase 1/21 (100.0%)

Trials by Status

completed1100%

Recent Activity

0 active trials
Showing 1 of 1
completedphase_1_2

Stem Cell Gene Therapy for Sickle Cell Disease

NCT02247843

Clinical Trials (1)

Showing 1 of 1 trials
NCT02247843Phase 1/2

Stem Cell Gene Therapy for Sickle Cell Disease

Completed

All 1 trials loaded

Drug Details

Intervention Type
Biological
Total Trials
1